Skip to main content
Top
Published in: Journal of Nanoparticle Research 10/2013

01-10-2013 | Research Paper

Enhancement of bioavailability by formulating rhEPO ionic complex with lysine into PEG–PLA micelle

Authors: Yanan Shi, Fengying Sun, Dan Wang, Renyu Zhang, Changlin Dou, Wanhui Liu, Kaoxiang Sun, Youxin Li

Published in: Journal of Nanoparticle Research | Issue 10/2013

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

A composite micelle of ionic complex encapsulated into poly(ethylene glycol)-poly(d,l-lactide) (PEG–PLA) di-block copolymeric micelles was used for protein drug delivery to improve its pharmacokinetic performance. In this study, recombinant human erythropoietin (rhEPO, as a model protein) was formulated with lysine into composite micelles at a diameter of 71.5 nm with narrow polydispersity indices (PDIs < 0.3). Only a trace amount of protein was in aggregate form. The zeta potential of the spherical micelles was ranging from −0.54 to 1.39 mv, and encapsulation efficiency is high (80 %). The stability of rhEPO was improved significantly in composite micelles in vitro. Pharmacokinetic studies in rats showed significant, enhanced plasma retention of the composite micelles in comparison with native rhEPO. Areas under curve (AUCs) of the rhEPO released from the composite micelles were 4.5- and 2.3-folds higher than those of the native rhEPO and rhEPO-loaded PEG–PLA micelle, respectively. In addition, the composite micelles exhibited good biocompatibility using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay with human embryonic kidney (HEK293T) cells. All these features are preferable for utilizing the composite micelles as a novel protein delivery system.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Literature
go back to reference Bae ATYH (2007) Role of a novel excipient poly(ethylene glycol)-b-poly(l-histidine) in retention of physical stability of insulin in aqueous solutions. Pharm Res 24:1517–1526CrossRef Bae ATYH (2007) Role of a novel excipient poly(ethylene glycol)-b-poly(l-histidine) in retention of physical stability of insulin in aqueous solutions. Pharm Res 24:1517–1526CrossRef
go back to reference Chao Fang BS, Pei Y-Y, Hong M-H, Jiang W, Chen H-Z (2006) In vivo tumor targeting of tumor necros is factor-α-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. Eur J Pharm Sci 27:27–36CrossRef Chao Fang BS, Pei Y-Y, Hong M-H, Jiang W, Chen H-Z (2006) In vivo tumor targeting of tumor necros is factor-α-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. Eur J Pharm Sci 27:27–36CrossRef
go back to reference Chiu GNC, Abraham SA, Ickenstein LM, Ng R, Karlsson G, Edwards K, Wasan EK, Bally MB (2005) Encapsulation of doxorubicin into thermosensitive liposomes via complexation with the transition metal manganese. J Control Release 104:271–288CrossRef Chiu GNC, Abraham SA, Ickenstein LM, Ng R, Karlsson G, Edwards K, Wasan EK, Bally MB (2005) Encapsulation of doxorubicin into thermosensitive liposomes via complexation with the transition metal manganese. J Control Release 104:271–288CrossRef
go back to reference Davis ME (2008) Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 7:771–782CrossRef Davis ME (2008) Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 7:771–782CrossRef
go back to reference Emile C, Bazile D, Herman F, Helene C, Veillard M (1996) Encapsulation of oligonucleotides in stealth Me. PEG–PLA50 nanoparticles by complexation with structured oligopeptides. Drug Delivery 3:187–195CrossRef Emile C, Bazile D, Herman F, Helene C, Veillard M (1996) Encapsulation of oligonucleotides in stealth Me. PEG–PLA50 nanoparticles by complexation with structured oligopeptides. Drug Delivery 3:187–195CrossRef
go back to reference Francis GE, Fisher D, Delgado C, Malik F, Gardiner A, Neale D (1998) PEGylation of cytokines and other therapeutic proteins and peptides: the importance of biological optimisation of coupling techniques. Int J Hematol 68:1–18CrossRef Francis GE, Fisher D, Delgado C, Malik F, Gardiner A, Neale D (1998) PEGylation of cytokines and other therapeutic proteins and peptides: the importance of biological optimisation of coupling techniques. Int J Hematol 68:1–18CrossRef
go back to reference Geng Y, Yuan W, Wu F, Chen J, He M, Jin T (2008) Formulating erythropoietin-loaded sustained-release PLGA microspheres without protein aggregation. J Control Release 130:259–265CrossRef Geng Y, Yuan W, Wu F, Chen J, He M, Jin T (2008) Formulating erythropoietin-loaded sustained-release PLGA microspheres without protein aggregation. J Control Release 130:259–265CrossRef
go back to reference Govender T, Riley T, Ehtezazi T, Garnett MC, Stolnik S, Illum L, Davis SS (2000) Defining the drug incorporation properties of PLA–PEG nanoparticles. Int J Pharm 199:95–110CrossRef Govender T, Riley T, Ehtezazi T, Garnett MC, Stolnik S, Illum L, Davis SS (2000) Defining the drug incorporation properties of PLA–PEG nanoparticles. Int J Pharm 199:95–110CrossRef
go back to reference Graul A, Cruces E, Dulsat C, Arias E, Stringer M (2012) The year’s new drugs & biologics, 2011. Drugs Today (Barc) 48:33–77 Graul A, Cruces E, Dulsat C, Arias E, Stringer M (2012) The year’s new drugs & biologics, 2011. Drugs Today (Barc) 48:33–77
go back to reference Gref R, Lück M, Quellec P, Marchand M, Dellacherie E, Harnisch S, Blunk T, Müller R (2000) ‘Stealth’corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B 18:301–313CrossRef Gref R, Lück M, Quellec P, Marchand M, Dellacherie E, Harnisch S, Blunk T, Müller R (2000) ‘Stealth’corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B 18:301–313CrossRef
go back to reference Hahn SK, Oh EJ, Miyamoto H, Shimobouji T (2006) Sustained release formulation of erythropoietin using hyaluronic acid hydrogels crosslinked by Michael addition. Int J Pharm 322:44–51CrossRef Hahn SK, Oh EJ, Miyamoto H, Shimobouji T (2006) Sustained release formulation of erythropoietin using hyaluronic acid hydrogels crosslinked by Michael addition. Int J Pharm 322:44–51CrossRef
go back to reference Han C, Davis CB, Wang B (2010) Evaluation of drug candidates for preclinical development: pharmacokinetics, metabolism, pharmaceutics, and toxicology. Wiley, Hoboken, p 12 Han C, Davis CB, Wang B (2010) Evaluation of drug candidates for preclinical development: pharmacokinetics, metabolism, pharmaceutics, and toxicology. Wiley, Hoboken, p 12
go back to reference He J, Feng M, Zhou X, Ma S, Jiang Y, Wang Y, Zhang H (2011) Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer. Int J Pharm 416:69–76CrossRef He J, Feng M, Zhou X, Ma S, Jiang Y, Wang Y, Zhang H (2011) Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer. Int J Pharm 416:69–76CrossRef
go back to reference Hoffman AS, Stayton PS, Bulmus V, Chen G, Chen J, Cheung C, Chilkoti A, Ding Z, Dong L, Fong R (2000) Really smart bioconjugates of smart polymers and receptor proteins. J Biomed Mater Res 52:577–586CrossRef Hoffman AS, Stayton PS, Bulmus V, Chen G, Chen J, Cheung C, Chilkoti A, Ding Z, Dong L, Fong R (2000) Really smart bioconjugates of smart polymers and receptor proteins. J Biomed Mater Res 52:577–586CrossRef
go back to reference Jang WD, Nakagishi Y, Nishiyama N, Kawauchi S, Morimoto Y, Kikuchi M, Kataoka K (2006) Polyion complex micelles for photodynamic therapy: incorporation of dendritic photosensitizer excitable at long wavelength relevant to improved tissue-penetrating property. J Control Release 113:73–79CrossRef Jang WD, Nakagishi Y, Nishiyama N, Kawauchi S, Morimoto Y, Kikuchi M, Kataoka K (2006) Polyion complex micelles for photodynamic therapy: incorporation of dendritic photosensitizer excitable at long wavelength relevant to improved tissue-penetrating property. J Control Release 113:73–79CrossRef
go back to reference Kataoka K, Harada A, Nagasaki Y (2001) Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliver Rev 47:113–131CrossRef Kataoka K, Harada A, Nagasaki Y (2001) Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliver Rev 47:113–131CrossRef
go back to reference Kuwabara T, Ishikawa Y, Kobayashi H, Kobayashi S, Sugiyama Y (1995) Renal clearance of a recombinant granulocyte colony-stimulating factor, nartograstim, in rats. Pharm Res 12:1466–1469CrossRef Kuwabara T, Ishikawa Y, Kobayashi H, Kobayashi S, Sugiyama Y (1995) Renal clearance of a recombinant granulocyte colony-stimulating factor, nartograstim, in rats. Pharm Res 12:1466–1469CrossRef
go back to reference Kwak HH, Shim WS, Choi MK, Son MK, Kim YJ, Yang HC, Kim TH, Lee GI, Kim BM, Kang SH, Shim CK (2009) Development of a sustained-release recombinant human growth hormone formulation. J Control Release 137:160–165CrossRef Kwak HH, Shim WS, Choi MK, Son MK, Kim YJ, Yang HC, Kim TH, Lee GI, Kim BM, Kang SH, Shim CK (2009) Development of a sustained-release recombinant human growth hormone formulation. J Control Release 137:160–165CrossRef
go back to reference Luo YL, Yuan JF, Shi JH, Gao QY (2010) Synthesis and characterization of polyion complex micelles and their controlled release of folic acid. J Colloid Interface Sci 350:140–147CrossRef Luo YL, Yuan JF, Shi JH, Gao QY (2010) Synthesis and characterization of polyion complex micelles and their controlled release of folic acid. J Colloid Interface Sci 350:140–147CrossRef
go back to reference Macdougall IC, Eckardt KU (2006) Novel strategies for stimulating erythropoiesis and potential new treatments for anaemia. Lancet 368:947–953CrossRef Macdougall IC, Eckardt KU (2006) Novel strategies for stimulating erythropoiesis and potential new treatments for anaemia. Lancet 368:947–953CrossRef
go back to reference Marsh D, Bartucci R, Sportelli L (2003) Lipid membranes with grafted polymers: physico-chemical aspects. BBA-Biomembranes 1615:33–59CrossRef Marsh D, Bartucci R, Sportelli L (2003) Lipid membranes with grafted polymers: physico-chemical aspects. BBA-Biomembranes 1615:33–59CrossRef
go back to reference Morlock M, Koll H, Winter G, Kissel T (1997) Microencapsulation of rh-erythropoietin, using biodegradable poly(d, l-lactide-co-glycolide): protein stability and the effects of stabilizing excipients. Eur J Pharm Biopharm 43:29–36CrossRef Morlock M, Koll H, Winter G, Kissel T (1997) Microencapsulation of rh-erythropoietin, using biodegradable poly(d, l-lactide-co-glycolide): protein stability and the effects of stabilizing excipients. Eur J Pharm Biopharm 43:29–36CrossRef
go back to reference Nguyen CA, Allémann E, Schwach G, Doelker E, Gurny R (2003) Cell interaction studies of PLA–MePEG nanoparticles. Int J Pharm 254:69–72CrossRef Nguyen CA, Allémann E, Schwach G, Doelker E, Gurny R (2003) Cell interaction studies of PLA–MePEG nanoparticles. Int J Pharm 254:69–72CrossRef
go back to reference Owens DE, Peppas NA (2006) Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307:93–102CrossRef Owens DE, Peppas NA (2006) Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307:93–102CrossRef
go back to reference Pistel K, Bittner B, Koll H, Winter G, Kissel T (1999) Biodegradable recombinant human erythropoietin loaded microspheres prepared from linear and star-branched block copolymers: influence of encapsulation technique and polymer composition on particle characteristics. J Control Release 59:309–325CrossRef Pistel K, Bittner B, Koll H, Winter G, Kissel T (1999) Biodegradable recombinant human erythropoietin loaded microspheres prepared from linear and star-branched block copolymers: influence of encapsulation technique and polymer composition on particle characteristics. J Control Release 59:309–325CrossRef
go back to reference Ryan SM, Mantovani G, Wang X, Haddleton DM, Brayden DJ (2008) Advances in PEGylation of important biotech molecules: delivery aspects. Expert Opin Drug Deliv 5:371–383CrossRef Ryan SM, Mantovani G, Wang X, Haddleton DM, Brayden DJ (2008) Advances in PEGylation of important biotech molecules: delivery aspects. Expert Opin Drug Deliv 5:371–383CrossRef
go back to reference Salmaso S, Caliceti P (2011) A useful tool to improve the biological performance of biotech drugs. In: van der Walle C (ed) Peptide and protein delivery. Elsevier Health Sciences, London, pp 247–290CrossRef Salmaso S, Caliceti P (2011) A useful tool to improve the biological performance of biotech drugs. In: van der Walle C (ed) Peptide and protein delivery. Elsevier Health Sciences, London, pp 247–290CrossRef
go back to reference Salmaso S, Caliceti P (2013) Self assembling nanocomposites for protein delivery: supramolecular interactions of soluble polymers with protein drugs. Int J Pharm 440:111–123CrossRef Salmaso S, Caliceti P (2013) Self assembling nanocomposites for protein delivery: supramolecular interactions of soluble polymers with protein drugs. Int J Pharm 440:111–123CrossRef
go back to reference Salmaso S, Bersani S, Semenzato A, Caliceti P (2006) Nanotechnologies in protein delivery. J Nanosci Nanotechnol 6:9–10CrossRef Salmaso S, Bersani S, Semenzato A, Caliceti P (2006) Nanotechnologies in protein delivery. J Nanosci Nanotechnol 6:9–10CrossRef
go back to reference Sandanaraj BS, Vutukuri DR, Simard JM, Klaikherd A, Hong R, Rotello VM, Thayumanavan S (2005) Non-covalent modification of chymotrypsin surface using amphiphilic polymeric scaffold–implications in modulating protein function. J Am Chem Soc 127:10693–10698CrossRef Sandanaraj BS, Vutukuri DR, Simard JM, Klaikherd A, Hong R, Rotello VM, Thayumanavan S (2005) Non-covalent modification of chymotrypsin surface using amphiphilic polymeric scaffold–implications in modulating protein function. J Am Chem Soc 127:10693–10698CrossRef
go back to reference Sato AK, Viswanathan M, Kent RB, Wood CR (2006) Therapeutic peptides: technological advances driving peptides into development. Curr Opin Biotechnol 17:638–642CrossRef Sato AK, Viswanathan M, Kent RB, Wood CR (2006) Therapeutic peptides: technological advances driving peptides into development. Curr Opin Biotechnol 17:638–642CrossRef
go back to reference Shi Y, Huang W, Liang R, Sun K, Zhang F, Liu W, Li Y (2013) Improvement of in vivo efficacy of recombinant human erythropoietin by encapsulation in PEG–PLA micelle. Int J Nanomedicine 8:1–11CrossRef Shi Y, Huang W, Liang R, Sun K, Zhang F, Liu W, Li Y (2013) Improvement of in vivo efficacy of recombinant human erythropoietin by encapsulation in PEG–PLA micelle. Int J Nanomedicine 8:1–11CrossRef
go back to reference Stolnik S, Garnett M, Davies M, Illum L, Bousta M, Vert M, Davis S (1995) The colloidal properties of surfactant-free biodegradable nanospheres from poly (β-malic acid-co-benzyl malate) s and poly (lactic acid-co-glycolide. Colloid Surf A 97:235–245CrossRef Stolnik S, Garnett M, Davies M, Illum L, Bousta M, Vert M, Davis S (1995) The colloidal properties of surfactant-free biodegradable nanospheres from poly (β-malic acid-co-benzyl malate) s and poly (lactic acid-co-glycolide. Colloid Surf A 97:235–245CrossRef
go back to reference Tanaka H, Okada Y, Kawagishi M, Tokiwa T (1989) Pharmacokinetics and pharmaco-dynamics of recombinant human granulocyte-colony stimulating factor after intravenous and subcutaneous administration in the rat. J Pharmacol Exp Ther 272:1199–1203 Tanaka H, Okada Y, Kawagishi M, Tokiwa T (1989) Pharmacokinetics and pharmaco-dynamics of recombinant human granulocyte-colony stimulating factor after intravenous and subcutaneous administration in the rat. J Pharmacol Exp Ther 272:1199–1203
go back to reference Tian H, Deng C, Lin H, Sun J, Deng M, Chen X, Jing X (2005) Biodegradable cationic PEG–PEI–PBLG hyperbranched block copolymer: synthesis and micelle characterization. Biomaterials 26:4209–4217CrossRef Tian H, Deng C, Lin H, Sun J, Deng M, Chen X, Jing X (2005) Biodegradable cationic PEG–PEI–PBLG hyperbranched block copolymer: synthesis and micelle characterization. Biomaterials 26:4209–4217CrossRef
go back to reference Torchilin VP (2001) Structure and design of polymeric surfactant-based drug delivery systems. J Control Release 73:137CrossRef Torchilin VP (2001) Structure and design of polymeric surfactant-based drug delivery systems. J Control Release 73:137CrossRef
go back to reference Venkatesan N, Uchino K, Amagase K, Ito Y, Shibata N, Takada K (2006) Gastro-intestinal patch system for the delivery of erythropoietin. J Control Release 111:19–26CrossRef Venkatesan N, Uchino K, Amagase K, Ito Y, Shibata N, Takada K (2006) Gastro-intestinal patch system for the delivery of erythropoietin. J Control Release 111:19–26CrossRef
go back to reference Veronese FM, Mero A (2008) The impact of PEGylation on biological therapies. BioDrugs 22:315–329CrossRef Veronese FM, Mero A (2008) The impact of PEGylation on biological therapies. BioDrugs 22:315–329CrossRef
go back to reference Wakebayashia D, Nishiyama N, Yamasakia Y, Itakaa K, Kanayamaa N, Harada A, Nagasakid Y, Kataoka K (2004) Lactose conjugated polyion complex micelles incorporating plasmid DNA as a targetable gene vector system: their preparation and gene transfecting efficiency against cultured HepG2 cells. J Control Release 95:653–664CrossRef Wakebayashia D, Nishiyama N, Yamasakia Y, Itakaa K, Kanayamaa N, Harada A, Nagasakid Y, Kataoka K (2004) Lactose conjugated polyion complex micelles incorporating plasmid DNA as a targetable gene vector system: their preparation and gene transfecting efficiency against cultured HepG2 cells. J Control Release 95:653–664CrossRef
go back to reference Walgren JL, Thompson DC (2004) Application of proteomic technologies in the drug development process. Toxicol Lett 149:377–385CrossRef Walgren JL, Thompson DC (2004) Application of proteomic technologies in the drug development process. Toxicol Lett 149:377–385CrossRef
go back to reference Wang CH, Wang CH, Hsiue GH (2005) Polymeric micelles with a pH-responsive structure as intracellular drug carriers. J Control Release 108:140–149CrossRef Wang CH, Wang CH, Hsiue GH (2005) Polymeric micelles with a pH-responsive structure as intracellular drug carriers. J Control Release 108:140–149CrossRef
go back to reference Wenquan L (2003) Biopharmaceutics and pharmacokinetics, 2nd edn. People’s Medical Publishing House, Beijing, p 113 Wenquan L (2003) Biopharmaceutics and pharmacokinetics, 2nd edn. People’s Medical Publishing House, Beijing, p 113
go back to reference Yang KW, Li XR, Yang ZL, Li PZ, Wang F, Liu Y (2009) Novel polyion complex micelles for liver-targeted delivery of diammonium glycyrrhizinate: in vitro and in vivo characterization. J Biomed Mater Res A 88:140–148 Yang KW, Li XR, Yang ZL, Li PZ, Wang F, Liu Y (2009) Novel polyion complex micelles for liver-targeted delivery of diammonium glycyrrhizinate: in vitro and in vivo characterization. J Biomed Mater Res A 88:140–148
go back to reference Zeng Q (2004) Organic chemistry, 4th edn. Higher Education Press, Beijing 11 Zeng Q (2004) Organic chemistry, 4th edn. Higher Education Press, Beijing 11
go back to reference Zigang Y, Fen Z, Jianjun Y, Lixin M, Chao Z, Shiyuan C (2006) Preparation of PLL–PEG–PLL and its application to DNA encapsulation. Sci China Ser B 49:357–362CrossRef Zigang Y, Fen Z, Jianjun Y, Lixin M, Chao Z, Shiyuan C (2006) Preparation of PLL–PEG–PLL and its application to DNA encapsulation. Sci China Ser B 49:357–362CrossRef
Metadata
Title
Enhancement of bioavailability by formulating rhEPO ionic complex with lysine into PEG–PLA micelle
Authors
Yanan Shi
Fengying Sun
Dan Wang
Renyu Zhang
Changlin Dou
Wanhui Liu
Kaoxiang Sun
Youxin Li
Publication date
01-10-2013
Publisher
Springer Netherlands
Published in
Journal of Nanoparticle Research / Issue 10/2013
Print ISSN: 1388-0764
Electronic ISSN: 1572-896X
DOI
https://doi.org/10.1007/s11051-013-2002-x

Other articles of this Issue 10/2013

Journal of Nanoparticle Research 10/2013 Go to the issue

Premium Partners